Acetazolamide D3 is a deuterium-labeled variant of the research compound acetazolamide, where three hydrogen atoms are replaced by deuterium. It is primarily used as a research reagent for analytical and metabolic studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1189904-01-5
5-({3,5-Dimethoxy-4-[(²H₃)methyloxy]phenyl}methyl)pyrimidine-2,4-diamine
research compound
2-Amino-9-({[1,3-dihydroxy(²H₅)propan-2-yl]oxy}methyl)-3,9-dihydro-6H-purin-6-one
research compound
Peptide YY human
research compound
Pteroic acid
research compound
Acetazolamide
pharmaceutical raw material
5-acetamido-1,3,4-thiadiazole-2-sulfonic acid
pharmaceutical intermediate
Sulfohydrazide
pharmaceutical intermediate
5-Amino-1,3,4-thiadiazole-2-sulfonamide Hydrochloride Salt
pharmaceutical intermediate
2,2,2-trideuterio-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
BZKPWHYZMXOIDC-FIBGUPNXSA-N
[2H]C([2H])([2H])C(=O)NC1=NN=C(S1)S(=O)(=O)N